XM은(는) 미국 국적의 시민에게 서비스를 제공하지 않습니다.
I
I

Incyte


뉴스

U.S. BlackRock, Goldman Sachs, Netflix

U.S. RESEARCH ROUNDUP-BlackRock, Goldman Sachs, Netflix July 16 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including BlackRock, Goldman Sachs and Netflix, on Tuesday. HIGHLIGHTS * Ameriprise Financial Inc AMP.N : RBC raises target price to $487 from $480 * BlackRock BLK.N : JP Morgan raises target price to $774 from $756 * Goldman Sachs GS.N : HSBC raises target price to $527 from $493 * Moody's Corp MCO.N : JP Morgan rai
B
C
G
I
N
D
G
S
W
A
P

U.S. STOCKS Helios Technologies, Indivior, Principal Financial

BUZZ-U.S. STOCKS ON THE MOVE-Helios Technologies, Indivior, Principal Financial Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 The S&P 500 and the Nasdaq hovered at record highs on Tuesday, propelled by gains in Nvidia and other megacaps, as U.S.
I
I
N
P
T
C
U
U
S

U.S. STOCKS Tesla, Archer Aviation, Novo Nordisk

BUZZ-U.S. STOCKS ON THE MOVE-Tesla, Archer Aviation, Novo Nordisk Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 The Nasdaq and the S&P 500 edged up on Tuesday, boosted by gains in Tesla and megacap stocks, while the Dow was flat with investors assessing Federal Reserve Chairman Jerome Powell's comments on the need for more evidence before cutting rates.
I
P
P
P
P
T
L
O
W
U
U
U

U.S. STOCKS Tesla, Pure Storage, Rivian

BUZZ-U.S. STOCKS ON THE MOVE-Tesla, Pure Storage, Rivian Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street indexes traded lower on Tuesday after Federal Reserve Chairman Jerome Powell said more evidence was needed before cutting interest rates, while gains in Tesla shares kept losses in check.
I
P
P
T
L
O
W
U
U
U

U.S. STOCKS PayPal, Paramount Global, Novo Nordisk

BUZZ-U.S. STOCKS ON THE MOVE-PayPal, Paramount Global, Novo Nordisk Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street was on track for a lower open on Tuesday as megacap stocks retreated after a strong session, with additional caution creeping in ahead of jobs opening data and comments from Federal Reserve Chairman Jerome Powell later in the day.
I
P
T
U
R

U.S. STOCKS Atlassian, Comerica, Tesla

BUZZ-U.S. STOCKS ON THE MOVE-Atlassian, Comerica, Tesla Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 U.S. stock index futures fell on Tuesday as megacap stocks retreated after a strong session, with additional caution creeping in ahead of jobs opening data and comments from Federal Reserve Chairman Jerome Powell later in the day.
I
T
U
R

Incyte drops after BMO downgrades to 'underperform'

BUZZ-Incyte drops after BMO downgrades to 'underperform' ** Shares of drugmaker Incyte Corp INCY.O down ~3% at $59.01 in premarket trading ** BMO Capital Markets cuts stock to "underperform" from "market perform"; trims PT to $48 from $52 ** Says co's $2 bln Dutch auction has cut capacity to acquire while generating minimal incremental value for sh
I

U.S. Deckers Brands, Nvidia, Workday

U.S. RESEARCH ROUNDUP-Deckers Brands, Nvidia, Workday May 24 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies including Deckers Brands, Nvidia and Workday, on Friday. HIGHLIGHTS * Deckers Brands DECK.N : Barclays raises target price to $1089 from $1026 * Enersys ENS.N : BTIG cuts to neutral from buy * Nvidia Corp NVDA.O : Deutsche Bank raises target price to $1000 * Ulta Beauty Inc ULTA.O : Jefferies cuts target price to $412 fr
A
I
I
N
A
R
U

S&P 500 top and bottom performing stocks at about 03:30 p.m. EDT

BUZZ - S&P 500 top and bottom performing stocks at about 03:30 p.m. EDT S&P 500 .SPX Top Performers Percent Change Incyte Corp INCY.OQ +8.2% Moderna Inc MRNA.OQ +6.3% Walgreens Boots Alliance Inc WBA.OQ +5.6% American Airlines Group Inc AAL.OQ +4.1% Carmax Inc KMX.N +3.9% Bottom Performers Percent Change Mettler-Toledo International Inc MTD.N -4.0%
I
W
A
U
H
C
M

U.S. STOCKS Annexon, MKS Instruments, Robinhood

BUZZ-U.S. STOCKS ON THE MOVE-Annexon, MKS Instruments, Robinhood Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 U.S. stock indexes edged higher on Monday, nearing record highs after a recent run of gains, as investors awaited key inflation figures this week to gauge the likelihood of interest rate cuts in 2024. .N At 11:58 a.m.
A
C
G
G
I
N
U
U
H
C
M

S&P 500 top and bottom performing stocks at about 12:00 p.m. EDT

BUZZ - S&P 500 top and bottom performing stocks at about 12:00 p.m. EDT S&P 500 .SPX Top Performers Percent Change Incyte Corp INCY.OQ +7.4% Carmax Inc KMX.N +5.1% Walgreens Boots Alliance Inc WBA.OQ +4.6% Moderna Inc MRNA.OQ +4.5% American Airlines Group Inc AAL.OQ +4.3% Bottom Performers Percent Change Mettler-Toledo International Inc MTD.N -2.5%
I
W
A
U
H
U
C
M

Incyte jumps on $2 bln share buyback plan

BUZZ-Incyte jumps on $2 bln share buyback plan ** Shares of Incyte INCY.O jump 6.2% premarket to $56.35, over 1-mth high, as biopharma firm announces $2 bln stock buyback plan ** Co commences modified "Dutch Auction" tender offer to repurchase shares for aggregate purchase price of up to $1.672 bln ** In addition, co entered into stock purchase agreement with Baker Bros Advisors, top INCY holder (per LSEG), to repurchase up to $328 worth of shares to enable the investment manager to maintain its
I

Incyte Announces Intention To Buy Back Up To $2.0 Billion Of Its Common Stock

BRIEF-Incyte Announces Intention To Buy Back Up To $2.0 Billion Of Its Common Stock May 13 (Reuters) - Incyte Corp INCY.O : INCYTE ANNOUNCES INTENTION TO BUY BACK UP TO $2.0 BILLION OF ITS COMMON STOCK INCYTE CORP - INCYTE COMMENCES DUTCH AUCTION TENDER OFFER TO REPURCHASE UP TO $1.67 BILLION OF OUTSTANDING COMMON SHARES Source text for Eikon: ID:n
I

U.S. STOCKS Molson Coors, Starbucks, Warner Bros Discovery

BUZZ-U.S. STOCKS ON THE MOVE-Molson Coors, Starbucks, Warner Bros Discovery Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street's main indexes fell on Tuesday with caution prevailing ahead of the Federal Reserve's interest-rate decision and as stronger-than-expected labor costs hinted at persistent inflation.
A
I
P
P
S
T
A
S
U
U
E
R
G
L
M
T

U.S. STOCKS Zebra Technologies, Ecolab, American Electric Power

BUZZ-U.S. STOCKS ON THE MOVE-Zebra Technologies, Ecolab, American Electric Power Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street's main indexes fell on Tuesday with caution prevailing ahead of the Federal Reserve's interest-rate decision and as stronger-than-expected labor costs hinted at persistent inflation.
I
P
P
T
C
S
U
U
E
R
G
L
T

Incyte Corp reports results for the quarter ended in March - Earnings Summary

Incyte Corp reports results for the quarter ended in March - Earnings Summary Incyte Corp INCY.OQ reported quarterly adjusted earnings of 64 cents​​ per share for the quarter ended in March, higher than the same quarter last year, when the company reported EPS of 37 cents. The mean expectation of twenty analysts for the quarter was for earnings of 84 cents per share.
I

Incyte misses quarterly profit on weak sales of lead drug

Incyte misses quarterly profit on weak sales of lead drug April 30 (Reuters) - Incyte Corp INCY.O on Tuesday reported first-quarter profit below Wall Street estimates on weak sales of its blood cancer drug Jakafi, sending its shares down 2.4%. The company is working on strengthening its pipeline to counter competition from newly approved drugs, which could impact sales of Jakafi, the company's biggest-selling drug, as it nears the loss of exclusivity later this decade.
I
M
N

U.S. STOCKS LendingTree, Leidos, Roku

BUZZ-U.S. STOCKS ON THE MOVE-LendingTree, Leidos, Roku Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Futures tracking Wall Street's main indexes were subdued on Tuesday as investors refrained from placing big bets ahead of the Federal Reserve's interest rate decision and kept a close eye on a stream of earnings updates.
I
P
T
C
S
U
R
L

Incyte Corp falls on lower-than-expected revenue, profit

BUZZ-Incyte Corp falls on lower-than-expected revenue, profit ** Shares of drugmaker Incyte Corp INCY.O fall 2.9% to $51 premarket ** Co reports 9% growth in Q1 revenue of $880.9 mln, but misses analysts' estimates of $923.6 -LSEG data ** Posts Q1 adj.profit of 64 cents per share, also missing estimates of 84 cents per share- LSEG data ** Revenue f
I

Incyte Q1 Adjusted EPS USD 0.64 Vs. IBES Estimate USD 0.84

BRIEF-Incyte Q1 Adjusted EPS USD 0.64 Vs. IBES Estimate USD 0.84 Apr 30 (Reuters) - Incyte Q1 operating income USD 91.898 million. Q1 revenue USD 880.889 million vs. IBES estimate USD 923.6 million Q1 adjusted operating income USD 161.183 million vs. IBES estimate USD 206.3 million Q1 EPS USD 0.75
I



조건

인기 자산

면책조항: XM Group 회사는 체결 전용 서비스와 온라인 거래 플랫폼에 대한 접근을 제공하여, 개인이 웹사이트에서 또는 웹사이트를 통해 이용 가능한 콘텐츠를 보거나 사용할 수 있도록 허용합니다. 이에 대해 변경하거나 확장할 의도는 없습니다. 이러한 접근 및 사용에는 다음 사항이 항상 적용됩니다: (i) 이용 약관, (ii) 위험 경고, (iii) 완전 면책조항. 따라서, 이러한 콘텐츠는 일반적인 정보에 불과합니다. 특히, 온라인 거래 플랫폼의 콘텐츠는 금융 시장에서의 거래에 대한 권유나 제안이 아닙니다. 금융 시장에서의 거래는 자본에 상당한 위험을 수반합니다.

온라인 거래 플랫폼에 공개된 모든 자료는 교육/정보 목적으로만 제공되며, 금융, 투자세 또는 거래 조언 및 권고, 거래 가격 기록, 금융 상품 또는 원치 않는 금융 프로모션의 거래 제안 또는 권유를 포함하지 않으며, 포함해서도 안됩니다.

이 웹사이트에 포함된 모든 의견, 뉴스, 리서치, 분석, 가격, 기타 정보 또는 제3자 사이트에 대한 링크와 같이 XM이 준비하는 콘텐츠 뿐만 아니라, 제3자 콘텐츠는 일반 시장 논평으로서 "현재" 기준으로 제공되며, 투자 조언으로 여겨지지 않습니다. 모든 콘텐츠가 투자 리서치로 해석되는 경우, 투자 리서치의 독립성을 촉진하기 위해 고안된 법적 요건에 따라 콘텐츠가 의도되지 않았으며, 준비되지 않았다는 점을 인지하고 동의해야 합니다. 따라서, 관련 법률 및 규정에 따른 마케팅 커뮤니케이션이라고 간주됩니다. 여기에서 접근할 수 있는 앞서 언급한 정보에 대한 비독립 투자 리서치 및 위험 경고 알림을 읽고, 이해하시기 바랍니다.

리스크 경고: 고객님의 자본이 위험에 노출 될 수 있습니다. 레버리지 상품은 모든 분들에게 적합하지 않을수 있습니다. 당사의 리스크 공시를 참고하시기 바랍니다.